Enovis Balance Sheet Health
Financial Health criteria checks 3/6
Enovis has a total shareholder equity of $3.3B and total debt of $1.3B, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are $5.6B and $2.2B respectively. Enovis's EBIT is $29.4M making its interest coverage ratio 0.6. It has cash and short-term investments of $35.4M.
Key information
40.4%
Debt to equity ratio
US$1.35b
Debt
| Interest coverage ratio | 0.6x |
| Cash | US$35.43m |
| Equity | US$3.33b |
| Total liabilities | US$2.22b |
| Total assets | US$5.55b |
Recent financial health updates
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Sep 24
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Jun 07Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Recent updates
Enovis Corporation's (NYSE:ENOV) Shares Not Telling The Full Story
Dec 13Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Sep 24It's A Story Of Risk Vs Reward With Enovis Corporation (NYSE:ENOV)
Aug 20Enovis Languishing Despite Respectable Performance
Jul 15Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Jun 07Enovis: Solid Growth, But Unstable Financial Footing
May 05Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks
Apr 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Feb 12Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14Investors Holding Back On Enovis Corporation (NYSE:ENOV)
Dec 18Calculating The Fair Value Of Enovis Corporation (NYSE:ENOV)
Nov 05Enovis Making Good Choices, But Not Seeing The Rewards
Sep 27Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Aug 03Enovis Corporation: Things Are Looking Good As Guidance Is Raised
Jul 18We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Enovis Corporation Q4 2022 Earnings Preview
Feb 22Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Is Enovis Corporation (NYSE:ENOV) Worth US$60.5 Based On Its Intrinsic Value?
Jan 25Enovis Corporation reports Q3 earnings beat; updates FY22 guidance
Nov 02Is Enovis (NYSE:ENOV) A Risky Investment?
Oct 19Is Enovis Corporation (NYSE:ENOV) Trading At A 27% Discount?
Sep 14Enovis launches augmented reality system ARVIS for use in hip, knee surgery
Jul 19Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly
Jul 05Enovis announces CFO transition
Jun 30Enovis: Medtech Leftover Of Colfax With Some To Prove
May 23As The Colfax Chapter Ends, Both ESAB And Enovis Have Something To Prove
Apr 05Financial Position Analysis
Short Term Liabilities: ENOV's short term assets ($1.2B) exceed its short term liabilities ($530.2M).
Long Term Liabilities: ENOV's short term assets ($1.2B) do not cover its long term liabilities ($1.7B).
Debt to Equity History and Analysis
Debt Level: ENOV's net debt to equity ratio (39.3%) is considered satisfactory.
Reducing Debt: ENOV's debt to equity ratio has reduced from 128.7% to 40.4% over the past 5 years.
Debt Coverage: ENOV's debt is not well covered by operating cash flow (7%).
Interest Coverage: ENOV's interest payments on its debt are not well covered by EBIT (0.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:36 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Enovis Corporation is covered by 35 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| null null | Baird |
| Robert Cornell | Barclays |